114 related articles for article (PubMed ID: 4353374)
1. [Activation of ifosfamide in man and animal].
Brock N; Hoefer-Janker H; Hohorst HJ; Scheef W; Schneider B; Wolf HC
Arzneimittelforschung; 1973 Jan; 23(1):1-14. PubMed ID: 4353374
[No Abstract] [Full Text] [Related]
2. [Quantitative determination of ifosfamide and an ifosfamide metabolite in the human urine].
Norpoth K; Wüst G; Witting U
Verh Dtsch Ges Inn Med; 1972; 78():1561-4. PubMed ID: 4353149
[No Abstract] [Full Text] [Related]
3. Isophosphamide as a new acrolein-producing antineoplastic isomer of cyclophosphamide.
Alarcon RA; Meienhofer J; Atherton E
Cancer Res; 1972 Nov; 32(11):2519-23. PubMed ID: 5082597
[No Abstract] [Full Text] [Related]
4. Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K
J Med Chem; 1974 Nov; 17(11):1237-9. PubMed ID: 4416021
[No Abstract] [Full Text] [Related]
5. [Comparison of ifosfamid with cyclophosphamide in the therapy of rat DS carcinosarcoma].
von Ardenne M; Reitnauer PG; Rohde K
Arch Geschwulstforsch; 1971; 38(1):15-26. PubMed ID: 4334130
[No Abstract] [Full Text] [Related]
6. Evidence for an aldehyde possessing alkylating activity as the primary metabolite of cyclophosphamide.
Sladek NE
Cancer Res; 1973 Apr; 33(4):651-8. PubMed ID: 4696466
[No Abstract] [Full Text] [Related]
7. [Absorption and organ distribution of the new antidepressant azaphen].
Siniukhin VN
Farmakol Toksikol; 1973; 26(4):409-11. PubMed ID: 4789881
[No Abstract] [Full Text] [Related]
8. Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
Hill DL; Laster WR; Kirk MC; el-Dareer S; Struck RF
Cancer Res; 1973 May; 33(5):1016-22. PubMed ID: 4703116
[No Abstract] [Full Text] [Related]
9. Activation of the antineoplastic drug isophosphamide by rat liver microsomes.
Allen LM; Creaven PJ
J Pharm Pharmacol; 1972 Jul; 24(7):585-6. PubMed ID: 4403857
[No Abstract] [Full Text] [Related]
10. Reactions of 2,2-dimethylaziridine-type alkylating agents in biological systems II: comparative pharmacokinetics in dogs.
Lalka D; Jusko WJ; Bardos TJ
J Pharm Sci; 1975 Feb; 64(2):230-5. PubMed ID: 236372
[No Abstract] [Full Text] [Related]
11. Teratogenicity and neonatal toxicity of ifosfamide in mice.
Bus JS; Gibson JE; Reinke DA
Proc Soc Exp Biol Med; 1973 Sep; 143(4):965-70. PubMed ID: 4743716
[No Abstract] [Full Text] [Related]
12. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cyclophosphamide and other homologous oxazaphosphorine-2-oxides on transplantation-immunologic reactions].
Müller-Ruchholtz W
Arzneimittelforschung; 1974 Aug; 24(8):1160-7. PubMed ID: 4370872
[No Abstract] [Full Text] [Related]
14. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.
Connors TA; Cox PJ; Farmer PB; Foster AB; Jarman M
Biochem Pharmacol; 1974 Jan; 23(1):115-29. PubMed ID: 4811053
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1979 Sep; 8(3):209-17. PubMed ID: 497087
[No Abstract] [Full Text] [Related]
16. [Experiences with single high dosage iphosphamide therapy in metastasizing malignant neoplasms].
Drings P; Fritsch H
Verh Dtsch Ges Inn Med; 1972; 78():166-9. PubMed ID: 4353153
[No Abstract] [Full Text] [Related]
17. [Alkylating cytostatic agents].
Schmidt CG
Internist (Berl); 1971; 12():Suppl 1:119-27. PubMed ID: 5002874
[No Abstract] [Full Text] [Related]
18. Metabolism and biological activity of retinoyl amide in rat.
John J; Mallia AK; Cama HR
Int J Vitam Nutr Res; 1971; 41(1):5-11. PubMed ID: 5125377
[No Abstract] [Full Text] [Related]
19. Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.
Booth BP; Rahman A; Dagher R; Griebel D; Lennon S; Fuller D; Sahajwalla C; Mehta M; Gobburu JV
J Clin Pharmacol; 2007 Jan; 47(1):101-11. PubMed ID: 17192508
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of isophosphamide.
Creaven PJ; Allen LM; Alford DA; Cohen MH
Clin Pharmacol Ther; 1974 Jul; 16(1):77-86. PubMed ID: 4602057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
